Gelteq Limited Ordinary Shares (GELS) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Gelteq Limited Ordinary Shares (GELS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $4.0M, listed on NASDAQ, employing roughly 7 people, carrying a beta of 0.08 to the broader market. Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. Led by Nathan Jacob Givoni, public since 2024-10-29.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for GELS as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →